| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44715 | |||
| Azide and BSA Free | NBP2-34519-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-84589-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61811-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52644-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54625-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52710-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54624-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52669-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44714 | |||
| Azide and BSA Free | NBP2-34412-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44715 | |||
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123C3.D5 + 123A8) [NBP2-34280] - Formalin-fixed, paraffin-embedded human Lung Carcinoma stained with CD56 Monoclonal Antibody (123C3.D5 + 123A8)](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123C3-D5-+-123A8-Immunohistochemistry-Paraffin-NBP2-34280-img0003.jpg "Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123C3.D5 + 123A8) [NBP2-34280] - Formalin-fixed, paraffin-embedded human Lung Carcinoma stained with CD56 Monoclonal Antibody (123C3.D5 + 123A8)")
![Flow Cytometry: NCAM-1/CD56 Antibody (123C3.D5 + 123A8) [NBP2-34280] - Flow cytometry of lymphocyte gated PBMCs unstained (gray) or stained with CF568-labeled NCAM-1/CD56 antibody (123C3.D5 + 123A8) (orange).](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123C3-D5-+-123A8-Flow-Cytometry-NBP2-34280-img0004.jpg)
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123C3.D5 + 123A8) [NBP2-34280] - Analysis using the Azide and BSA Free version of NBP2-34280. Staining of human colon ganglion stained with CD56 MAb (123C3.D5+123A8).](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123C3-D5-+-123A8-Immunohistochemistry-Paraffin-NBP2-34280-img0001.jpg)
![Flow Cytometry: Siglec-3/CD33 Antibody (WM53) - Low Endotoxin, Azide and BSA Free [NBP3-09095] - Mass cytometry (surface staining) of human peripheral blood with anti-CD33 (WM53) 149Sm. Gated on singlets.](http://images.novusbio.com/fullsize/Siglec-3-CD33-Antibody-WM53-Low-Endotoxin-Azide-and-BSA-Free-Flow-Cytometry-NBP3-09095-img0002.jpg "Flow Cytometry: Siglec-3/CD33 Antibody (WM53) - Low Endotoxin, Azide and BSA Free [NBP3-09095] - Mass cytometry (surface staining) of human peripheral blood with anti-CD33 (WM53) 149Sm. Gated on singlets.")
![Flow Cytometry: Siglec-3/CD33 Antibody (WM53) - Low Endotoxin, Azide and BSA Free [NBP3-09095] - Analysis (surface staining) of human peripheral blood with anti-CD33 (WM53) purified antibody (low endotoxin), GAM-APC.](http://images.novusbio.com/fullsize/Siglec-3-CD33-Antibody-WM53-Low-Endotoxin-Azide-and-BSA-Free-Flow-Cytometry-NBP3-09095-img0001.jpg)
![Western Blot: Fc gamma RI/CD64 Antibody (37F7) [NBP2-42685] - The recombinant protein (20ug) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human FCGR1A antibody (1:1000). Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system.](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-37F7-Western-Blot-NBP2-42685-img0006.jpg "Western Blot: Fc gamma RI/CD64 Antibody (37F7) [NBP2-42685] - The recombinant protein (20ug) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human FCGR1A antibody (1:1000). Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system.")
![Immunocytochemistry/Immunofluorescence: Fc gamma RI/CD64 Antibody (37F7) [NBP2-42685] - Analysis of FCGR1A in Jurkat cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human FCGR1A antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green).](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-37F7-Immunocytochemistry-Immunofluorescence-NBP2-42685-img0004.jpg)
![Flow Cytometry: Fc gamma RI/CD64 Antibody (37F7) [NBP2-42685] - Analysis of FCGR1A in Jurkat cell line, staining at 2-5ug for 1x106cells (red line). The secondary antibody used goat anti-mouse IgG Alexa fluor 488 conjugate. Isotype control antibody was mouse IgG (black line).](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-37F7-Flow-Cytometry-NBP2-42685-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: Fc gamma RI/CD64 Antibody (37F7) [NBP2-42685] - Analysis of FCGR1A in HeLa cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human FCGR1A antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green).](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-37F7-Immunocytochemistry-Immunofluorescence-NBP2-42685-img0003.jpg)
![Flow Cytometry: Fc gamma RI/CD64 Antibody (37F7) [NBP2-42685] - Analysis of FCGR1A in HeLa cell line, staining at 2-5ug for 1x106cells (red line). The secondary antibody used goat anti-mouse IgG Alexa fluor 488 conjugate. Isotypecontrol antibody was mouse IgG (black line).](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-37F7-Flow-Cytometry-NBP2-42685-img0007.jpg)
![Western Blot: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Analysis using KIR3DL1 mAb against human KIR3DL1 (AA: extra 22-340) recombinant protein. (Expected MW is 65 kDa)](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9F6-Western-Blot-NBP2-61811-img0003.jpg "Western Blot: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Analysis using KIR3DL1 mAb against human KIR3DL1 (AA: extra 22-340) recombinant protein. (Expected MW is 65 kDa)")
![Immunohistochemistry: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Analysis of paraffin-embedded cervical cancer tissues using KIR3DL1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9F6-Immunohistochemistry-NBP2-61811-img0002.jpg)
![Western Blot: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Analysis using KIR3DL1 mouse mAb against A431 (1), Raji (2), SPC-A-1 (3), K562 (4), HEK293 (5), U937 (6), C6 (7), and COS7 (8) cell lysate.](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9F6-Western-Blot-NBP2-61811-img0004.jpg)
![ELISA: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9F6-ELISA-NBP2-61811-img0001.jpg)
![Western Blot: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Analysis of human granulocyte lysate: Detection using 10 ug/ml Anti-CEACAM5 [5C8C4] followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Western-Blot-NBP2-54625-img0008.jpg "Western Blot: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Analysis of human granulocyte lysate: Detection using 10 ug/ml Anti-CEACAM5 [5C8C4] followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.")
![Flow Cytometry: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Binding of 10 ug/ml primary positive control mAb (upper panel), Anti-CEACAM5 [5C8C4] (lower panel), negative isotype matched control mAb (thin line) on different CHO-human CEACAM transfected cells (the CEACAM family member expressed is stated above).](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Flow-Cytometry-NBP2-54625-img0003.jpg)
![ELISA: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Solid phase was coated with 3 ug/ml Anti-CEA (Dako) binding human CEACAM1-CEACAM8. After washing, blocking and coating human CEACAM1 antigen, detecting antibody Anti-CEACAM5/8 [5C8C4] (10 ug/ml) followed by HRP-coupled goat anti-mouse Ig was added. TMB was used for visualizing the binding measured by Tecan-ELISA reader at 450 nm.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-ELISA-NBP2-54625-img0002.jpg)
![Immunoprecipitation: CEACAM-5/CD66e Antibody (5C8C4) [NBP2-54625] - Human granulocyte lysate: Utilizing 10 ug/ml Anti-CEACAM5/8 [5C8C4]. Detection of the sample using 5 ug/ml pAb Anti-CEA followed by HRP coupled secondary pAb. Visualized by Chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-5C8C4-Immunoprecipitation-NBP2-54625-img0006.jpg)
![Western Blot: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Detection using 10 ug/ml Anti-CEACAM3/5 [308/3-3] followed by HRP-coupled secondary pAb. Visualized by chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM3-5-Antibody-308-3-3-Western-Blot-NBP2-54624-img0004.jpg "Western Blot: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Detection using 10 ug/ml Anti-CEACAM3/5 [308/3-3] followed by HRP-coupled secondary pAb. Visualized by chemiluminescence detection.")
![Flow Cytometry: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Binding of 10 ug/ml primary positive control mAb (upper panel), Anti-CEACAM3/5 [308/3-3] (lower panel), negative isotype matched control mAb (thin line) on different CHO-human CEACAM transfected cells (the CEACAM family member expressed is stated above).](http://images.novusbio.com/fullsize/CEACAM3-5-Antibody-308-3-3-Flow-Cytometry-NBP2-54624-img0002.jpg)
![Sandwich ELISA: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Solid phase was coated with 3 ug/ml Anti-CEA (Dako) binding human CEACAM1-CEACAM8. After washing, blocking and coating human CEACAM1 antigen, detecting antibody Anti-CEACAM3/5 [308/3-3] (10 ug/ml) followed by HRP-coupled goat anti-mouse Ig was added. TMB was used for visualizing the binding measured by Tecan-ELISA reader at 450 nm.](http://images.novusbio.com/fullsize/CEACAM3-5-Antibody-308-3-3-Sandwich-ELISA-NBP2-54624-img0001.jpg)
![Immunoprecipitation: CEACAM3/5 Antibody (308/3-3) [NBP2-54624] - Immunoprecipitation utilizing 10 ug/ml Anti-CEACAM3/5 [308/3-3]. Detection of the sample using 5 ug/ml pAb Anti-CEA (Dako) followed by HRP-coupled secondary pAb. Visualized by chemiluminescence detection.](http://images.novusbio.com/fullsize/CEACAM3-5-Antibody-308-3-3-Immunoprecipitation-NBP2-54624-img0003.jpg)
![Western Blot: NCAM-1/CD56 Antibody (735) - Chimeric [NBP2-52669] - Rat brain lysate was resolved on a 10% SDS PAGE gel and blots probed with NBP2-52669 at 2 ug/ml before being detected by a secondary antibody.](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-735-Chimeric-Western-Blot-NBP2-52669-img0003.jpg "Western Blot: NCAM-1/CD56 Antibody (735) - Chimeric [NBP2-52669] - Rat brain lysate was resolved on a 10% SDS PAGE gel and blots probed with NBP2-52669 at 2 ug/ml before being detected by a secondary antibody.")
![Immunohistochemistry: NCAM-1/CD56 Antibody (735) - Chimeric [NBP2-52669] - Formalin fixed rat spinal chord slices were were stained with a NBP2-52669 at 3 ug/ml.](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-735-Chimeric-Immunohistochemistry-NBP2-52669-img0004.jpg)
![Immunohistochemistry: NCAM-1/CD56 Antibody (735) - Chimeric [NBP2-52669] - Formalin fixed guinea pig brain slices were were stained with a NBP2-52669 at 3 ug/ml.](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-735-Chimeric-Immunohistochemistry-NBP2-52669-img0001.jpg)
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (SPM489) [NBP2-34364] - Formalin-fixed, paraffin-embedded human colon stained with CD56 Monoclonal Antibody (SPM489)](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-SPM489-Immunohistochemistry-Paraffin-NBP2-34364-img0003.jpg "Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (SPM489) [NBP2-34364] - Formalin-fixed, paraffin-embedded human colon stained with CD56 Monoclonal Antibody (SPM489)")
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (SPM489) [NBP2-34364] - Analysis using the Azide and BSA Free version of NBP2-34364. Staining of human neuro-endocrine tumor stained with CD56 MAb (SPM489).](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-SPM489-Immunohistochemistry-Paraffin-NBP2-34364-img0002.jpg)
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (SPM489) [NBP2-34364] - Analysis using the Azide and BSA Free version of NBP2-34364. Staining of human colon ganglion stained with CD56 MAb (SPM489).](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-SPM489-Immunohistochemistry-Paraffin-NBP2-34364-img0001.jpg)
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123C3.D5 + 123A8) - Azide and BSA Free [NBP2-34519] - Formalin-fixed, paraffin-embedded human Lung Carcinoma stained with CD56 Monoclonal Antibody (123C3.D5 + 123A8)](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123C3-D5-+-123A8-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-34519-img0003.jpg "Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123C3.D5 + 123A8) - Azide and BSA Free [NBP2-34519] - Formalin-fixed, paraffin-embedded human Lung Carcinoma stained with CD56 Monoclonal Antibody (123C3.D5 + 123A8)")
![Flow Cytometry: NCAM-1/CD56 Antibody (123C3.D5 + 123A8) - Azide and BSA Free [NBP2-34519] - Flow cytometry of lymphocyte gated PBMCs unstained (gray) or stained with CF568-labeled NCAM-1/CD56 antibody (123C3.D5 + 123A8) (orange).](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123C3-D5-+-123A8-Azide-and-BSA-Free-Flow-Cytometry-NBP2-34519-img0004.jpg)
![Immunohistochemistry-Paraffin: NCAM-1/CD56 Antibody (123C3.D5 + 123A8) - Azide and BSA Free [NBP2-34519] - Formalin-paraffin human colon ganglion stained with CD56 MAb (123C3.D5+123A8)](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-123C3-D5-+-123A8-Azide-and-BSA-Free-Immunohistochemistry-Paraffin-NBP2-34519-img0001.jpg)